Ilumya – Display Banners Conference – Fall Clinical – 80817

April Armstrong, MD, MPH, spoke with Physician’s Weekly about the role of interleukin inhibitors, IL-17 and IL-23, in treating psoriasis.

The benefits of interleukin inhibitors vary by agent and include increased drug survival and earlier attainment of Psoriasis Area Severity Index scores.

Dermatologists must be knowledgeable about differences among people of color with psoriasis and to tailor their approach to diagnosis and treatment accordingly.

Educational and research gaps in treating plaque psoriasis in patients with skin of color can lead to delays in diagnosis and treatment.

Fall Clinical Dermatology Conference is providing a free live stream for some of the sessions. The live stream allows doctors who are not able to attend in person.

Find the list of Fall Clinical Dermatology Conference’s learning objectives, and follow along for PW coverage.

Take a look at the agenda for Fall Clinical Dermatology Conference. And follow along at PW for conference coverage.